Dr. Cassandra Gipson

https://is1-ssl.mzstatic.com/image/thumb/Podcasts115/v4/1d/c9/a2/1dc9a2f6-4287-36e4-d408-4e4277f5fb0a/mza_7199369665615234828.jpg/600x600bb.jpg

The Addiction Psychologist

Samuel Acuff and Noah Emery

66 episodes

1 day ago

Drs. Noah Emery and Samuel Acuff interview researchers, clinicians, and policymakers in the field of addiction psychology with the hopes of enhancing recovery. Official podcast of the Society for Addiction Psychology.

Social Sciences

Science

RSS

All content for The Addiction Psychologist is the property of Samuel Acuff and Noah Emery and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.

Social Sciences

Science

https://d3t3ozftmdmh3i.cloudfront.net/staging/podcast_uploaded_episode/6019556/6019556-1710096520386-47de133fc8f12.jpg

Dr. Cassandra Gipson - Xylazine

The Addiction Psychologist

58 minutes 36 seconds

1 year ago

Dr. Cassandra Gipson - Xylazine

In the past few years, a novel adulterant, Xylazine, has emerged in the illicit opioid drug supply. Between 2020 and 2021, there was a more than 1000% increase in xylazine-positive overdose mortalities in the United States from 2020 to 2021. What is Xylazine? How does it work? Why has it emerged in the supply? Dr. Cassandra Gipson-Reichardt discusses emerging literature on Xylazine and answers our questions on this episode of the Addiction Psychologist podcast. Dr. Gipson is an associate professor in the department of pharmacology and nutritional sciences at the University of Kentucky.